The Economic Times daily newspaper is available online now.

    Wockhardt initiates phase-III clinical study of new antibiotic candidate

    Synopsis

    WCK 5222 is a drug, which is entirely a new class of antibiotic known as "β-lactam ENHANCER", and is targeted for treatment of hospitalised adults with complicated urinary tract infections, including acute pyelonephritis, Wockhardt said in a statement.

    Drug thinkstockGetty Images
    (Representative image)
    Pharmaceutical firm Wockhardt Ltd on Tuesday said it has initiated a global Phase III clinical study of its new antibiotic candidate WCK 5222. The company has completed the first site initiation visit for the study, Wockhardt said in a statement.

    WCK 5222 is a drug, which is entirely a new class of antibiotic known as "β-lactam ENHANCER", and is targeted for treatment of hospitalised adults with complicated urinary tract infections, including acute pyelonephritis, it added.

    "WCK 5222 is a new class of antibiotic for gram-negative terrain for complicated urinary tract infections and hospital-acquired bacterial pneumonia (HABP/VABP)," Wockhardt Chairman Habil Khorakiwala said.

    Scientific evidence clearly suggests WCK 5222, when available, will save many lives worldwide, he added.

    The company said its study will have 70 centres worldwide in 11 countries, including the US, Europe, India, China and Latin America.

    "This global study is expected to be completed in 18 months," it added.


    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    ...more
    The Economic Times

    Stories you might be interested in